Publications by authors named "Patricia J Noel"
Article Synopsis
- There are thousands of biomarker tests for lung diseases, but many are being used in clinics before enough is known about their effectiveness and impact on health outcomes.
- A group of experts reviewed the current state of these tests across various lung diseases, identifying gaps in knowledge that need to be filled to improve their clinical application.
- While the potential for these biomarker tests to enhance clinical care is significant, challenges remain in validating their effectiveness, ensuring they meet clinical needs, and facilitating their integration into standard medical practice.
The National Heart, Lung, and Blood Institute (NHLBI), one of the 27 Institutes/Centers within the National Institutes of Health (NIH), has a strong interest in promoting translational research. This interest can be traced to its mission statement, which reads in part: “The NHLBI stimulates basic discoveries about the causes of disease, enables the translation of basic discoveries into clinical practice, fosters training and mentoring of emerging scientists and physicians, and communicates research advances to the public.” (www.
View Article and Find Full Text PDFFuture Research Directions in Asthma. An NHLBI Working Group Report.
Am J Respir Crit Care Med
December 2015
Asthma is a common chronic disease without cure. Our understanding of asthma onset, pathobiology, classification, and management has evolved substantially over the past decade; however, significant asthma-related morbidity and excess healthcare use and costs persist. To address this important clinical condition, the NHLBI convened a group of extramural investigators for an Asthma Research Strategic Planning workshop on September 18-19, 2014, to accelerate discoveries and their translation to patients.
View Article and Find Full Text PDF